Key takeaways
- Insurance stocks are quietly compounding: Canadian insurers have been putting up strong returns thanks to higher interest rates boosting investment income and disciplined underwriting, making this one of the more overlooked corners of the Canadian market right now.
- Different flavors for different portfolios: This group covers real range, from Fairfax Financial’s value-driven, Berkshire-style approach to Manulife’s massive wealth management pivot in Asia, to Trisura’s specialty niche that’s been a growth standout among smaller names.
- Rate sensitivity cuts both ways: The same rising rate environment that’s been padding earnings could reverse if central banks start cutting aggressively, and any prolonged economic slowdown would pressure premium growth and claims experience across the board, so don’t treat these as set-and-forget holdings.
Insurance is one of those sectors where the business model is almost unfairly good. You collect premiums upfront, invest that float, and pay claims later. When done well, you’re essentially getting paid to hold other people’s money. That’s a structural advantage most industries would kill for, and it’s why the best insurance companies tend to compound wealth quietly over long periods.
The Canadian insurance space is more diverse than people realize. You’ve got life insurers with massive global operations, specialty players carving out profitable niches, and holding companies running investment portfolios worth tens of billions. These aren’t interchangeable businesses. A company like Manulife has a completely different risk profile than a specialty insurer like Trisura, and the way you evaluate them should reflect that. I’ve actually ranked all six Canadian insurance stocks from S tier down, and the quality gap between the top and bottom of the list is significant.
What’s kept me interested in this group is how well many of these names have performed while Canadian bank stocks have dealt with their own issues. Insurers benefited enormously from rising interest rates, which boosted investment income on their float. Now, with rates coming down, the question is whether that tailwind fades or whether operating improvements can pick up the slack.
Valuation dispersion is wide right now. Some of these companies trade at single-digit earnings multiples with solid dividend yields. Others command premiums because they’ve earned them through years of disciplined capital allocation. That spread creates real opportunity if you know what to look for.
The six names below range from strong dividend payers to growth-oriented compounders to deep value situations. I focused on balance sheet strength, return on equity consistency, and whether management has a track record of smart capital deployment, because in insurance, that’s what separates the winners from the value traps.
In This Article
- Fairfax Financial Holdings Limited (FFH.TO)
- Trisura Group Ltd. (TSU.TO)
- Intact Financial Corporation (IFC.TO)
- Definity Financial Corp. (DFY.TO)
- Manulife Financial Corporation (MFC.TO)
- Sagicor Financial Company Ltd. (SFC.TO)
Fairfax Financial Holdings Limited (TSX: FFH)
Fairfax Financial Holdings Limited is a diversified financial holding company whose core business is property and casualty (P&C) insurance and reinsurance. The company operates through a decentralized structure, with major insurance subsidiaries including Northbridge Financial (Canadian commercial P&C), Crum & Forster (U.S...
Competitive Edge
- Prem Watsa's decentralized model, letting subsidiary CEOs run their own underwriting shops, creates accountability at the operating level that centralized insurers like AIG historically struggled with. Each unit owns its combined ratio.
- The Odyssey Group and Brit combination gives Fairfax access to both treaty reinsurance and Lloyd's specialty markets, two distribution channels that most competitors must choose between. This dual access creates pricing intelligence advantages.
- Geographic diversification across Canada, U.S., Asia, and international markets ($4.98B international net insurance revenue growing 10.5% YoY) provides natural catastrophe risk dispersion that pure domestic carriers cannot replicate.
- Fairfax's willingness to hold concentrated equity positions (historically Eurobank, Quess, IIFL) creates asymmetric upside that traditional insurers' conservative portfolios never capture. The non-insurance segment's 64.6% operating income growth reflects this.
- The IFRS 17 transition has made Fairfax's financials harder to compare with historical periods, creating a temporary analytical moat. Sophisticated investors who can bridge the accounting gap have an information edge over those who cannot.
By the Numbers
- Combined ratio improved from 95% in FY2021 to 92.7% in FY2024 before ticking up to 93% in FY2025. That sustained sub-95% performance across a $33B gross premium base generates over $1.8B in annual underwriting profit, a rare feat at this scale.
- Buyback yield of 9.2% with shares outstanding declining 2.1% YoY means management is aggressively retiring stock, not just offsetting SBC. At $3.16B in TTM repurchases versus only $184M in SBC, over 94% of buyback spend creates real per-share value.
- At 8.1x trailing P/E and 4.3x EV/EBITDA, the stock prices in zero growth despite 5Y EPS CAGR of 10.8%. Earnings yield of 12.3% versus a sub-1% dividend yield signals massive retained earnings compounding inside the business.
- International Insurers underwriting profit surged 111% YoY to $219M in FY2025, with the combined ratio likely dropping sharply as net premiums earned grew only 9.5%. This segment is inflecting from breakeven to meaningful contributor.
- Interest coverage at 10.8x is comfortable for a leveraged financial holding company. The investment portfolio is now generating substantial recurring income, with Global Insurers and Reinsurers alone producing $3.7B in operating income.
Risk Factors
- FCF-to-net-income conversion is deeply negative at -12.6%, and OCF-to-net-income is essentially zero at -0.6%. For an insurer, this likely reflects large investment portfolio movements distorting cash flow statements, but it makes traditional cash flow analysis nearly impossible.
- Global Insurers and Reinsurers operating income fell 14.2% YoY to $3.7B despite premiums earned growing 5%. The margin compression in Fairfax's largest segment, which drives over 55% of total operating income, is the single biggest earnings headwind.
- Life Insurance and Run-Off swung to a $214M operating loss in FY2025, a 132% deterioration YoY. This legacy book continues to be an unpredictable drag, and the $189M pre-tax loss suggests reserve strengthening or adverse development.
- Revenue declined 1.6% YoY on a trailing basis while analyst estimates project Y1 revenue of $31.8B, roughly a 37% drop from trailing $50.5B. This gap likely reflects reporting differences, but only 1 analyst covers revenue, creating an information vacuum.
- Specialty net insurance revenue declined 4.3% YoY after surging 49% the prior year. This boom-bust pattern in a segment that reached $2.5B suggests the growth was acquisition-driven rather than organic, raising integration and pricing discipline questions.
Trisura Group Ltd. (TSX: TSU)
Trisura Group Ltd. is a specialty property and casualty insurance company that operates primarily in Canada and the United States...
Competitive Edge
- Trisura's fronting/program model in the US shifts underwriting risk to reinsurers while collecting fee income. This asset-light structure generates returns on equity without requiring Trisura to bear catastrophic loss exposure directly.
- Specialty surety and D&O/E&O lines in Canada have high barriers to entry: broker relationships, regulatory licensing, and claims expertise create switching costs. Competitors like Intact or Travelers focus on larger accounts, leaving Trisura's niche less contested.
- The dual-geography model (Canadian specialty underwriting plus US fronting programs) provides diversification without the capital intensity of building a traditional US carrier. Few sub-$2B insurers have this structure.
- Management's decision to pay zero dividends and reinvest all earnings is the correct capital allocation for a specialty insurer still scaling its US platform. Book value per share compounding at 16% ROE without dividend drag maximizes long-term intrinsic value.
By the Numbers
- FCF-to-net-income ratio of 1.88x signals strong earnings quality. For a specialty insurer, cash generation exceeding reported earnings by this margin suggests conservative reserve practices rather than aggressive income recognition.
- Interest coverage at 184.6x with net cash of $88M means Trisura has virtually zero financial distress risk. The $199M in total debt is dwarfed by operating earnings, giving management maximum flexibility to grow the book.
- SBC-to-revenue at 0.09% is negligible, and share count grew only 0.6% YoY. Combined with $19.4M in buybacks (0.9% yield), management is actually shrinking the float on a net basis. Rare discipline for a sub-$2B market cap insurer.
- EV/EBITDA of 1.6x looks anomalously cheap, but this reflects the insurance accounting reality where float and reserves inflate the balance sheet. Still, at 13x trailing earnings with 16% ROE, the stock prices in almost no premium for a specialty compounder.
- 5-year revenue CAGR of 172% versus 3-year CAGR of 4.7% shows the US Programs segment has scaled massively. EPS still grew 31% CAGR over 3 years, proving the top-line buildout is now converting to bottom-line compounding.
Risk Factors
- Net margin of 4.8% against an operating margin of 37.6% reveals a massive gap, likely driven by loss reserves, ceded premiums, and investment-related items. If loss development turns adverse, that thin net margin has very little cushion.
- Revenue growth decelerated sharply: 1.6% YoY versus 4.7% 3-year CAGR and 172% 5-year CAGR. The Growth grade of 4.8/10 confirms the hypergrowth phase from US Programs scaling is over. Future returns depend on underwriting quality, not top-line expansion.
- Risk grade of 4.3/10 and Returns grade of 3.4/10 together suggest the stock's risk-adjusted return profile has deteriorated. Despite decent absolute profitability, the market is not rewarding the earnings stream with a premium multiple.
- Debt paydown yield is negative at -3.2%, meaning Trisura is adding leverage. Combined with the 0.9% buyback yield, total shareholder yield is actually negative at -2.3%. Capital is flowing away from shareholders toward balance sheet expansion.
- ROA of 18.2% looks unusually high for an insurer and likely reflects how gross written premiums flow through the income statement before cessions. This metric is misleading here and should not be taken at face value.
Intact Financial Corporation (TSX: IFC)
Intact Financial Corporation is a leading multinational property and casualty (P&C) insurance provider, operating primarily in Canada, the United States, the United Kingdom, and Ireland. In Canada, it is the largest P&C insurer, distributing products through a vast broker network, including its wholly-owned subsidiary BrokerLink, and directly to consumers under the belairdirect brand...
Competitive Edge
- Canada's P&C market is an oligopoly with high broker switching costs. IFC's 20%+ market share and ownership of BrokerLink creates a vertically integrated distribution advantage that competitors like Aviva Canada or Definity cannot easily replicate.
- The RSA acquisition gave IFC a specialty lines platform in the UK and Ireland with Lloyd's of London access. This diversifies catastrophe exposure away from Canadian weather events and provides access to hardening global specialty markets.
- IFC's data and AI capabilities in claims processing and pricing are a genuine cost advantage. Their investment in telematics and digital underwriting creates a feedback loop where better data leads to better risk selection, widening the gap against smaller regional carriers.
- Regulatory barriers in Canadian P&C insurance are significant. Provincial rate filing requirements, capital adequacy rules under OSFI, and the complexity of auto insurance regulation create a moat that deters new entrants and limits foreign competition.
- Management has a stated 10% NOIPS growth target and has consistently delivered through disciplined cycle management, buying market share during soft markets and harvesting during hard markets. This counter-cyclical playbook is rare and difficult to replicate.
By the Numbers
- Combined ratio improved from 94.2 in FY2023 to 88.2 in FY2025, a 600bps swing driven entirely by claims ratio compression (60.8 to 54.2). This is the best underwriting result in the dataset and signals disciplined reserving plus favorable loss trends.
- Canada operating income before tax surged 66.9% YoY to $2.66B on only 7.8% revenue growth, implying massive operating leverage as rate increases earned through while claims costs moderated. Canada now contributes 59% of segment operating income, up from ~47% two years ago.
- US segment operating income grew 23.2% YoY to $382M on just 5.6% revenue growth, with consistent margin expansion across all four years in the dataset. The US is quietly becoming a meaningful profit contributor with improving loss ratios.
- SBC-to-revenue at 0.16% is negligible for a $47B market cap company. Combined with a 1.4% buyback yield and 0.7% share count reduction, capital returns are genuine rather than offset by dilution. Total shareholder yield of 4.75% is real.
- Interest coverage at 28.5x with net debt of only $2B against ~$4B in unlevered FCF means the balance sheet is a source of optionality, not constraint. Debt paydown yield of 1% adds to total shareholder returns without sacrificing financial flexibility.
Risk Factors
- UK&I operating income dropped 25.6% YoY to $224M and the most recent quarter showed a $129M loss, a sharp reversal from $301M in FY2024. This segment represents 17% of premiums but is now destroying value on a quarterly run-rate basis.
- Expense ratio has crept higher every year, from 32.9 in FY2021 to 34.0 in FY2025. The combined ratio improvement is entirely claims-driven. If claims revert toward historical norms, there is no expense offset, and the 88.2 combined ratio could deteriorate quickly.
- Revenue growth has decelerated sharply: 5Y CAGR of 9.9% versus 3Y CAGR of 2.6% and YoY of 1.9%. The RSA acquisition in 2021 inflated the 5Y figure, and organic growth is now running in the low-to-mid single digits.
- EPS declined 1.4% YoY and EBITDA fell 10% YoY despite the strong combined ratio improvement. Investment income volatility in the corporate segment and the UK&I deterioration are masking what should be a much stronger earnings year from underwriting alone.
- Tangible book value per share of $66.71 versus price of $267 means the stock trades at 4x tangible book. Intangibles and goodwill represent 15.5% and 7.8% of assets respectively, reflecting acquisition-heavy growth that carries impairment risk if integration underperforms.
Definity Financial Corp. (TSX: DFY)
Definity Financial Corporation is one of Canada's leading property and casualty (P&C) insurers, tracing its roots back to 1871 before demutualizing and completing its initial public offering in 2021. The company operates a multi-channel distribution model, offering personal and commercial insurance products to individuals, small businesses, and mid-market companies...
Competitive Edge
- The Sonnet direct-to-consumer platform and the broker-facing Vyne digital channel give Definity two distribution routes most Canadian peers lack. Vyne in particular locks in broker workflow, which raises switching costs at the distribution layer rather than the customer layer.
- The demutualization left Definity with an unusually large capital base relative to its premium volume, funded partly by the Definity Insurance Foundation stake. That capital is the strategic weapon behind broker consolidation buys such as McDougall and the Travelers Canada deal.
- Canadian P&C remains fragmented below the top three (Intact, Desjardins, Aviva Canada), and broker-channel consolidation is the clearest path to scale. Definity is one of very few buyers with both listed currency and surplus capital to participate.
- Provincial rate regulation, especially Ontario auto, is a barrier to entry that punishes subscale entrants. Definity's multi-year expense ratio compression in auto, 28.5% to 25.4%, is exactly the kind of advantage that compounds when rate increases are capped by regulators.
- Pet insurance through Petline is a genuinely differentiated, low-severity, high-frequency book with far lower catastrophe correlation than home or auto, and it supports the group combined ratio in bad weather years.
By the Numbers
- Personal Property combined ratio fell 7.8 points to 88.5% in FY2025 from 96.3%, driven by the claims ratio dropping from 62.7% to 55.4%. Property is now the most profitable personal line, a reversal from FY2023 when it ran at 99.3%.
- Personal Insurance policies in force turned positive at plus 3.2% in FY2025 after two straight years of shrinkage (minus 1.5% and minus 0.2%), with auto units up 4.9%. Growth is now unit-driven rather than purely rate-driven, which is far more durable.
- Every line is underwriting at a profit at once: Commercial 89.3%, Property 88.5%, Auto 95.1%. Commercial has held under 90% for three consecutive years while its expense ratio ground down from 35.3% to 32.6%, showing scale benefits, not just a soft loss year.
- Auto expense ratio has compressed every year since FY2022, from 28.5% to 25.4%, a 3.1 point structural gain that persists regardless of weather or claims inflation. That is the part of the combined ratio management actually controls.
- EPS compounded 55% a year from FY2022 to FY2025 against revenue of 18% a year, with the decomposition attributing 31.6% a year to margin effect. Underwriting margin, not premium volume, did the heavy lifting.
Risk Factors
- Commercial claims ratio has crept up four years running, 54.8% to 56.7%, while personal lines improved sharply. Commercial premium growth also decelerated from 17.6% in FY2022 to 8.6% in FY2025, so the highest-margin book is slowing and its loss trend is drifting the wrong way.
- The FY2025 personal lines result leans on unusually low catastrophe activity: Property claims ratio at 55.4% is 7.3 points below FY2024 and roughly 9 points below the FY2021 to FY2023 average. Mean reversion in weather alone would erase most of the year's margin gain.
- Quarterly combined ratios are already running worse than the full-year figures: Personal Insurance 94.2% against 92.5% annual, Commercial 93.1% against 89.3%, Property 92.8% against 88.5%. The most recent quarter is the honest run-rate, not the FY2025 print.
- Share count grew 3.1% over the past year and 2.7% a year over five years, against a buyback yield of just 0.09%. Repurchases of $8.7m are not remotely offsetting issuance, so per-share economics lag the headline growth.
- Personal Auto combined ratio of 95.1% still leaves only 4.9 points of underwriting margin in the largest single line at $2.0bn of premium. Ontario auto reform delays or a 2 point claims miss would consume nearly half of it.
Manulife Financial Corporation (TSX: MFC)
Manulife Financial Corporation is a leading global financial services group providing life insurance, health insurance, and wealth management solutions. The company operates through several key segments: Insurance and Annuity Products, which offers individual life insurance, long-term care insurance, and group benefits; and Global Wealth and Asset Management, which provides mutual funds, exchange-traded funds, group retirement products, and institutional asset management services...
Competitive Edge
- Manulife's Asia distribution network across Hong Kong, Japan, Vietnam, and mainland China (via Manulife-Sinochem) creates a structural advantage that Western peers like MetLife and Prudential Financial cannot easily replicate. Agency force scale in these markets takes decades to build.
- The IFRS 17 transition has reset the earnings baseline, and Manulife's early adoption positions it ahead of peers in investor communication. The contractual service margin (CSM) backlog provides forward earnings visibility that traditional insurance accounting never offered.
- WAM's Manulife Investment Management platform manages C$808B across public and private markets, including timber and agriculture. These alternative asset capabilities command higher fees and stickier mandates than traditional fixed income, creating a differentiated asset management franchise.
- Manulife Bank of Canada provides direct-to-consumer banking that cross-sells into the insurance client base, a distribution synergy that pure-play insurers like Sun Life or Great-West lack. This integrated model improves customer lifetime value and retention.
- Asia's rising middle class and underpenetration of life insurance (protection gap exceeding US$80T across the region) provide a multi-decade secular tailwind. Manulife's top-3 market positions in Hong Kong, Vietnam, and Singapore place it directly in the path of this demand growth.
By the Numbers
- Asia APE sales grew 20.9% YoY to C$7.3B in FY2025, accelerating from 35.9% the prior year, now comprising 75% of total APE sales. This geographic mix shift toward Asia's higher-margin insurance products is structurally improving the consolidated expense efficiency ratio, which dropped from 48.9% in FY2021 to 44.8%.
- Total AUM reached C$1.38T with WAM segment generating C$2.25B in pre-tax income at a 30.4% margin on C$7.4B revenue. WAM pre-tax income grew at a 14.9% CAGR over three years, creating a fee-based earnings stream that reduces sensitivity to insurance reserve volatility.
- PEG ratio of 0.64 with forward P/E of 13.3x against consensus EPS growth from C$3.07 trailing to C$4.47 estimated (46% jump) signals the market is not fully pricing the IFRS 17 earnings normalization and Asia growth acceleration.
- Net debt is negative C$21B, meaning the company holds substantially more cash and investments than debt. Combined with 21.6x interest coverage, Manulife has significant balance sheet flexibility for capital returns and opportunistic M&A without needing to access debt markets.
- Share count declined 1.4% YoY with C$2.24B in buybacks, and the FCF payout ratio is just 11.1% versus an earnings payout ratio of 54.9%. This massive gap means the dividend is covered nearly 9x by free cash flow, leaving enormous room for buyback acceleration.
Risk Factors
- US segment swung to a C$527M net loss in FY2025 from C$135M profit in FY2024, a C$662M deterioration. US pre-tax income went from +C$132M to -C$708M, and the US expense efficiency ratio spiked from 24.5% to 32.9%, suggesting legacy long-term care or variable annuity reserve charges are resurfacing.
- Total AUM was essentially flat YoY at C$1.38T despite strong markets, with WAM AUM declining 0.1% and US AUM falling 6.2%. This stall after 14.8% growth the prior year suggests net outflows are offsetting market appreciation, a warning sign for fee revenue sustainability.
- ROE of 13.2% and ROIC of 2.8% reveal a wide gap, meaning most of the equity return is driven by financial leverage rather than operating efficiency. For a C$97B market cap insurer, sub-3% ROIC indicates the massive general account asset base generates thin spreads.
- Corporate and Other segment swung from C$81M net income to a C$88M loss, and its pre-tax income went from +C$335M to -C$314M. This C$649M pre-tax swing in a non-operating segment suggests hedging losses or one-time charges that management may be burying outside core segments.
- Canada APE sales declined 5.7% YoY in FY2025 after growing 19.9% the prior year. In the home market, this deceleration coincides with only 2% net income growth, suggesting the domestic insurance business is maturing and pricing competition is intensifying.
Sagicor Financial Company Ltd. (TSX: SFC)
Sagicor Financial Company Ltd. is a diversified financial services group with a strong presence in the Caribbean and a growing footprint in the United States...
Competitive Edge
- Sagicor's 180+ year operating history in the Caribbean creates deep distribution lock-in. Life insurance is a trust-intensive product, and in small island economies with limited competition, brand longevity functions as a regulatory-grade moat that new entrants cannot replicate.
- The US expansion through Sagicor Life Insurance Company provides geographic diversification into a deeper, more liquid market. This reduces concentration risk and gives access to US dollar investment-grade fixed income portfolios that improve asset-liability matching.
- Caribbean insurance markets have low penetration rates relative to developed markets, providing a long secular growth runway. As GDP per capita rises across the region, demand for life, health, and annuity products should grow faster than overall economic output.
- As a diversified financial services group offering insurance, banking, and asset management, Sagicor captures multiple points in the value chain. Cross-selling across product lines in concentrated markets creates higher customer lifetime value than pure-play insurers.
By the Numbers
- Trailing P/E of 3.3x vs forward P/E of 6.6x looks odd until you realize trailing EPS of $0.48 reflects volatile insurance accounting under IFRS 17, while consensus Y1 EPS of $0.94 implies a normalized earnings power roughly double the trailing figure. At 6.6x forward, the stock prices in zero growth.
- P/B of 0.84x with ROE of 18% is a genuine disconnect. The market is pricing Sagicor below liquidation value despite the company generating returns well above its cost of equity, suggesting the Caribbean discount is overdone relative to actual capital generation.
- Debt/equity of just 0.045x and net debt/EBITDA of 0.24x indicate the holding company balance sheet is essentially unlevered. For a life insurer, this is exceptionally clean and provides significant financial flexibility for acquisitions or capital returns.
- Shares outstanding declined 3.2% YoY, and combined with a 3% dividend yield and active buybacks, total shareholder yield is positive. The payout ratio of just 11% on earnings leaves enormous room for dividend growth or accelerated repurchases.
- Earnings yield of 30.7% vs a 3% dividend yield means the company is retaining roughly 90% of earnings. If redeployed at even half the current 18% ROE, compounding at this valuation could generate significant intrinsic value growth that the market is ignoring.
Risk Factors
- FCF is deeply negative at -$620M unlevered, and FCF/net income conversion is -0.07x. For an insurer this partly reflects reserve movements and investment portfolio cash flows, but the OCF/net income ratio of -0.03x signals that reported earnings are not translating into any cash generation whatsoever.
- Revenue declined 66% YoY, which likely reflects IFRS 17 reclassification of insurance revenue rather than organic decline. However, 5Y revenue CAGR of -8.4% and 5Y EPS CAGR of -54% suggest structural headwinds even adjusting for accounting changes. Only 1 analyst covers revenue, limiting estimate reliability.
- The Risk grade of 2.7/10 is the weakest score in the profile. Combined with negative operating cash flow and Caribbean geographic concentration, this flags meaningful tail risk that the low P/E alone does not compensate for.
- ROIC of just 1.0% dramatically trails ROE of 18%, revealing that the high ROE is driven almost entirely by the leverage inherent in the insurance balance sheet (policyholder liabilities), not by efficient capital deployment on invested capital.
- EPS growth 3Y CAGR of -20% and 5Y CAGR of -54% show a sustained earnings deterioration trend. The 289% YoY EPS spike looks like a recovery from a depressed base rather than a structural inflection, and forward estimates imply only modest growth beyond Y1 normalization.
Insurance is one of the few sectors where I genuinely think most investors would be better off owning two or three names instead of one. The business models across this group are different enough that combining a steady dividend payer with a more growth-oriented compounder actually reduces your risk in a meaningful way, not just on paper but in how the portfolio behaves quarter to quarter. That’s rare. Most sectors don’t give you that kind of natural diversification within the same industry.
What I keep thinking about is how forgiving the economics are when management is competent. Float is a gift. You’re investing someone else’s money before you ever have to pay a claim. But that gift turns into a curse fast when underwriting discipline slips or when someone gets cute with the investment portfolio. The gap between the best and worst names here isn’t just about returns. It’s about whether the business model is working for you or slowly working against you. Pick the wrong insurer and you’ll spend years watching book value go sideways while dividends barely cover inflation.
I’d focus on the names where management has proven they can underwrite profitably through a full cycle. That’s the real edge in this sector, not the dividend yield, not the P/E ratio. Cycle-tested discipline.